Patents by Inventor Qian Garrett

Qian Garrett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for reducing ocular discomfort
    Patent number: 10912752
    Abstract: The invention relates to compositions and devices which include an osmolytic agent, in particular a betaine or carnitine compound, for reducing ocular discomfort associated with various diseases or conditions, in particular diseases or conditions associated with high tear film tonicity. The invention also relates to methods of treating or preventing various diseases or conditions using compositions and devices of the invention.
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: February 9, 2021
    Assignee: Brien Holden Vision Institute Limited
    Inventor: Qian Garrett
  • METHODS AND COMPOSITIONS FOR REDUCING OCULAR DISCOMFORT
    Publication number: 20190167625
    Abstract: The invention relates to compositions and devices which include an osmolytic agent, in particular a betaine or carnitine compound, for reducing ocular discomfort associated with various diseases or conditions, in particular diseases or conditions associated with high tear film tonicity. The invention also relates to methods of treating or preventing various diseases or conditions using compositions and devices of the invention.
    Type: Application
    Filed: August 28, 2018
    Publication date: June 6, 2019
    Inventor: Qian Garrett
  • Methods and compositions for reducing ocular discomfort
    Patent number: 10085960
    Abstract: The invention relates to compositions and devices which include an osmolytic agent, in particular a betaine or carnitine compound, for reducing ocular discomfort associated with various diseases or conditions, in particular diseases or conditions associated with high tear film tonicity. The invention also relates to methods of treating or preventing various diseases or conditions using compositions and devices of the invention.
    Type: Grant
    Filed: March 28, 2013
    Date of Patent: October 2, 2018
    Assignee: Brien Holden Vision Institute
    Inventor: Qian Garrett
  • METHODS AND COMPOSITIONS FOR REDUCING OCULAR DISCOMFORT
    Publication number: 20150164844
    Abstract: The invention relates to compositions and devices which include an osmolytic agent, in particular a betaine or carnitine compound, for reducing ocular discomfort associated with various diseases or conditions, in particular diseases or conditions associated with high tear film tonicity. The invention also relates to methods of treating or preventing various diseases or conditions using compositions and devices of the invention.
    Type: Application
    Filed: March 28, 2013
    Publication date: June 18, 2015
    Inventor: Qian Garrett
  • LACTOFERRIN SEQENCES, COMPOSITIONS AND METHODS FOR CORNEAL WOUND TREATMENT
    Publication number: 20130101575
    Abstract: The present invention relates to pharmaceutical compositions containing lactoferrin, or fragments of it, and their use in the treatment of wounds, particularly corneal wounds. The present invention also provides a pharmaceutical composition comprising an effective amount of a polypeptide or peptidomimetic consisting essentially of the C-lobe of lactoferrin, or functionally active fragments or variants thereof.
    Type: Application
    Filed: July 1, 2011
    Publication date: April 25, 2013
    Applicant: Brien Holden Vision Institute
    Inventors: Benjamin David Ashby, Qian Garrett, Mark Willcox